The Immune Checkpoint Inhibitors Market in the US is gaining momentum as pharmaceutical companies, healthcare providers, and research institutions increasingly invest in advanced cancer immunotherapy.
Market Overview
The Immune Checkpoint Inhibitors Market size is expected to reach US$ 202.97 Billion by 2031. The market is anticipated to register a CAGR of 17.1% during 2025-2031.Immune...
